Weigao Group buys back 0.18 million H shares for HKD 0.58 million; treasury stock climbs to 58.81 million

Bulletin Express06-16

Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed that it repurchased 180,000 H shares on 16 June 2026 via the Hong Kong Stock Exchange at prices ranging from HKD 3.22 to HKD 3.23. The transaction involved a total consideration of HKD 0.58 million and represents 0.004 % of the company’s issued share capital, excluding treasury shares, prior to the repurchase.

Following the buy-back, Weigao Group’s issued shares (excluding treasury shares) decreased to 4,463.53 million, while treasury shares rose to 58.81 million. The total number of issued shares remained unchanged at 4,522.33 million.

The repurchase falls under the mandate approved by shareholders on 29 May 2026, which authorises the company to buy back up to 446.46 million shares. Including this latest transaction, Weigao Group has repurchased 1.48 million shares under the mandate to date, equivalent to 0.3315 % of the issued share count on the mandate’s approval date.

In accordance with Hong Kong listing rules, a 30-day moratorium on new share issues or treasury-share disposals is in place until 16 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1159866410?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-16 17:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159866410","market":"us","top_or_hot":-1,"title":"Weigao Group buys back 0.18 million H shares for HKD 0.58 million; treasury stock climbs to 58.81 million","media":"Bulletin Express","content":"<p>Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed that it repurchased 180,000 H shares on 16 June 2026 via the Hong Kong Stock Exchange at prices ranging from HKD 3.22 to HKD 3.23. The transaction involved a total consideration of HKD 0.58 million and represents 0.004 % of the company’s issued share capital, excluding treasury shares, prior to the repurchase.</p>\n<p>Following the buy-back, Weigao Group’s issued shares (excluding treasury shares) decreased to 4,463.53 million, while treasury shares rose to 58.81 million. The total number of issued shares remained unchanged at 4,522.33 million.</p>\n<p>The repurchase falls under the mandate approved by shareholders on 29 May 2026, which authorises the company to buy back up to 446.46 million shares. Including this latest transaction, Weigao Group has repurchased 1.48 million shares under the mandate to date, equivalent to 0.3315 % of the issued share count on the mandate’s approval date.</p>\n<p>In accordance with Hong Kong listing rules, a 30-day moratorium on new share issues or treasury-share disposals is in place until 16 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Weigao Group buys back 0.18 million H shares for HKD 0.58 million; treasury stock climbs to 58.81 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWeigao Group buys back 0.18 million H shares for HKD 0.58 million; treasury stock climbs to 58.81 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-16 17:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed that it repurchased 180,000 H shares on 16 June 2026 via the Hong Kong Stock Exchange at prices ranging from HKD 3.22 to HKD 3.23. The transaction involved a total consideration of HKD 0.58 million and represents 0.004 % of the company’s issued share capital, excluding treasury shares, prior to the repurchase.</p>\n<p>Following the buy-back, Weigao Group’s issued shares (excluding treasury shares) decreased to 4,463.53 million, while treasury shares rose to 58.81 million. The total number of issued shares remained unchanged at 4,522.33 million.</p>\n<p>The repurchase falls under the mandate approved by shareholders on 29 May 2026, which authorises the company to buy back up to 446.46 million shares. Including this latest transaction, Weigao Group has repurchased 1.48 million shares under the mandate to date, equivalent to 0.3315 % of the issued share count on the mandate’s approval date.</p>\n<p>In accordance with Hong Kong listing rules, a 30-day moratorium on new share issues or treasury-share disposals is in place until 16 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01066","symbol_name":"威高股份","start_time":0,"source_url":"","article_id":"1159866410","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159866410","pubTimestamp":1781602883,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed that it repurchased 180,000 H shares on 16 June 2026 via the Hong Kong Stock Exchange at prices ranging from HKD 3.22 to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01066":"威高股份"},"translate_title":"威高集团以58万港元回购18万股H股；库存股攀升至5881万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01066":1},"content_text":"Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed that it repurchased 180,000 H shares on 16 June 2026 via the Hong Kong Stock Exchange at prices ranging from HKD 3.22 to HKD 3.23. The transaction involved a total consideration of HKD 0.58 million and represents 0.004 % of the company’s issued share capital, excluding treasury shares, prior to the repurchase.\nFollowing the buy-back, Weigao Group’s issued shares (excluding treasury shares) decreased to 4,463.53 million, while treasury shares rose to 58.81 million. The total number of issued shares remained unchanged at 4,522.33 million.\nThe repurchase falls under the mandate approved by shareholders on 29 May 2026, which authorises the company to buy back up to 446.46 million shares. Including this latest transaction, Weigao Group has repurchased 1.48 million shares under the mandate to date, equivalent to 0.3315 % of the issued share count on the mandate’s approval date.\nIn accordance with Hong Kong listing rules, a 30-day moratorium on new share issues or treasury-share disposals is in place until 16 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1159866410","isCrawlerRequest":true}